Cardinal Health Inc
NYSE:CAH

  • LAST PRICE
    123.4200
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    123.0100/ 1
  • Ask / Lots
    196.2300/ 1
  • Open / Previous Close
    --- / 123.4200
  • Day Range
    ---
  • 52 Week Range
    93.1700
    126.1350
  • Volume
    25

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
CAH
Cardinal Health Inc
29.9B
24.0x
-5.30%
WBA
Walgreens Boots Alliance Inc
7.2B
-0.8x
---
MCK
Mckesson Corp
79.8B
32.6x
---
GRDN
Guardian Pharmacy Services Inc
1.4B
51.4x
---
TKLF
Tokyo Lifestyle Co Ltd
135.9M
0.2x
+17.60%
PETS
Petmed Express Inc
95.9M
-85.5x
---
As of 2024-11-22

Company Information

Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. The Company’s segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.

Contact Information

Headquarters
7000 Cardinal PlDUBLIN, OH, United States 43017
Phone
614-757-3033
Fax
614-757-6000

Executives

Independent Non-Executive Chairman of the Board
Gregory Kenny
Chief Executive Officer, Director
Jason Hollar
Chief Financial Officer
Aaron Alt
Corporate Executive - GMPD segment
Stephen Mason
Chief Executive Officer of Pharmaceutical and Specialty Solutions Segment
Deborah Weitzman

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
---
Revenue (TTM)
---
Shares Outstanding
---
Dividend Yield
1.64%
Annual Dividend Rate
2.0224 USD
Ex-Dividend Date
01-02-25
Pay Date
01-15-25
Beta
---
EPS
---
Book Value
---
P/E Ratio
24.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.